Palisade Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-250 |
Gross Profit | -1 | -1 | -304 | |
EBITDA | -3,480 | -4,077 | -3,525 | -3,291 |
EBIT | -3,481 | -4,078 | -3,526 | -3,334 |
Net Income | -3,487 | -4,080 | -3,527 | -2,971 |
Net Change In Cash | 0 | 0 | 0 | -250 |
Free Cash Flow | -3,133 | -3,499 | -3,180 | -2,746 |
Cash | 8,040 | 11,353 | 11,276 | 12,432 |
Basic Shares | 1,500 | 1,228 | 842 | 617 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $250 | $250 | $0 | $13 |
Gross Profit | 250 | -167 | -168 | -132 |
EBITDA | -12,281 | -15,308 | -24,050 | -9,941 |
EBIT | -12,285 | -15,475 | -24,218 | -10,087 |
Net Income | -12,300 | -12,799 | -27,271 | -10,570 |
Net Change In Cash | 250 | 250 | 0 | 13 |
Free Cash Flow | -11,137 | -13,370 | -14,773 | -4,774 |
Cash | 12,432 | 12,383 | 10,495 | 713 |
Basic Shares | 456 | 58 | 12 | 55 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.32 |
2024-06-30 | -$3.32 |
2024-03-31 | -$4.59 |
2023-12-31 | -$6.45 |
